Response to biologic therapy in Crohn's disease is improved with early treatment: an analysis of health claims data.
about
Magnetic resonance enterographic predictors of one-year outcome in ileal and ileocolonic Crohn's disease treated with anti-tumor necrosis factor antibodies.Early anti-TNF/immunomodulator therapy is associated with better long-term clinical outcomes in Asian patients with Crohn's disease with poor prognostic factorsA Retrospective Claims Database Study on Drug Utilization in Japanese Patients with Crohn's Disease Treated with Adalimumab or Infliximab.Management of inflammatory bowel disease in the elderly: do biologicals offer a better alternative?Stopping anti-TNF agents in patients with Crohn's disease in remission: is it a feasible long-term strategy?Multidisciplinary management of gastrointestinal fibrotic stenosis in Crohn's disease.Safety considerations when using anti-TNFα therapy to treat Crohn's disease.Anti-TNF levels and anti-drug antibodies, immunosuppressants and clinical outcomes in inflammatory bowel disease.Early histological findings may predict the clinical phenotype in Crohn's colitis.The future developments in inflammatory bowel disease care.Real-world assessment of therapy changes, suboptimal treatment and associated costs in patients with ulcerative colitis or Crohn's disease.Mathematical model of the roles of T cells in inflammatory bowel disease.Tissue studies in screened first-degree relatives reveal a distinct Crohn's disease phenotype.Conflicting results on the efficacy of enteral nutrition during infliximab maintenance therapy for Crohn's disease are correct.Comparative Study of Two Cohorts of Newly Diagnosed Crohn's Disease Demonstrates Change in Therapeutic Strategies.Top-down Versus Step-up Prescribing Strategies for Tumor Necrosis Factor Alpha Inhibitors in Children and Young Adults with Inflammatory Bowel Disease.How fast up the ladder? Factors associated with immunosuppressive or anti-TNF therapies in IBD patients at early stages: results from a population-based cohort.Home Sweet Home? Will Medical Homes Be Coming to Your Neighborhood Sometime Soon?
P2860
Q35627602-90AD98B4-2473-4E50-AB87-1B5D986A22C2Q36380315-DBA97EC5-802F-4B24-8C04-B1321F2362A3Q37373219-15DF3A59-6D80-4ED7-AC47-22426FA0E3B6Q38141975-513EDA67-45E6-432E-AF6D-878DD38B1099Q38191334-E5423C73-4746-46CE-9828-B73722DC1C88Q38266205-58E14E26-4AB6-4B94-8663-99EA5B72D752Q38268598-DB50E4B5-825F-4129-B4F8-CB8BA93871E5Q38323592-A3F141D2-2374-4CBF-AABD-19CB62270AE2Q38621241-FE634AC1-A2E6-4CA4-A5FD-DA1346A3275FQ39594232-B9B87C37-0991-4C0B-92E6-2DA9533DC36CQ43674654-27999835-108B-4B89-9400-D2D5CD135923Q44139974-72E984EF-343E-4473-8F6E-48D5DD7867CEQ44997544-3FA05931-F469-4962-9AA8-01C1DCAC77D7Q46713334-8A12C6C9-C729-44E5-81C7-871015F8043CQ48680314-4EDC0260-A14C-4EE6-9642-67B0E89D5DE1Q49109368-1C93024C-D4D7-4660-8AA6-D927D971D20CQ51058515-DFB3B686-F9A2-43F6-9B3D-C21BD0EA3731Q53992652-08CBB437-7B7B-4680-A6FD-636BC152C7F5
P2860
Response to biologic therapy in Crohn's disease is improved with early treatment: an analysis of health claims data.
description
2012 nî lūn-bûn
@nan
2012 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Response to biologic therapy i ...... nalysis of health claims data.
@ast
Response to biologic therapy i ...... nalysis of health claims data.
@en
Response to biologic therapy i ...... nalysis of health claims data.
@nl
type
label
Response to biologic therapy i ...... nalysis of health claims data.
@ast
Response to biologic therapy i ...... nalysis of health claims data.
@en
Response to biologic therapy i ...... nalysis of health claims data.
@nl
prefLabel
Response to biologic therapy i ...... nalysis of health claims data.
@ast
Response to biologic therapy i ...... nalysis of health claims data.
@en
Response to biologic therapy i ...... nalysis of health claims data.
@nl
P2093
P2860
P356
P1476
Response to biologic therapy i ...... nalysis of health claims data.
@en
P2093
David T Rubin
Ozgecan Uluscu
Robert Sederman
P2860
P304
P356
10.1002/IBD.22925
P577
2012-02-22T00:00:00Z